Home » Authors » Nuala Moran

Articles by Nuala Moran

Prolysis Gets $9.9M, Aims For Clinic By End Of 2006

June 1, 2005

Ardana Reports Positive Data In Teverelix LA Phase IIa Trial

June 1, 2005

Moving Fast, Astex Cleared For Clinical Trial Of AT 7519

May 25, 2005

ProStrakan Wants £50M IPO In Tough UK Public Market

May 25, 2005

Oxagen Brings In $59.8M; U.S. Firm As Lead Investor

May 25, 2005

Oxagen Brings In $59.8M; U.S. Firm As Lead Investor

May 25, 2005

ProStrakan Wants £50M IPO In Tough UK Public Market

May 25, 2005

Moving Fast, Astex Cleared For Clinical Trial Of AT 7519

May 25, 2005

Initiatives Aim To Make UK Top Spot For Clinical Trials

May 18, 2005

To Increase Pipeline, CAT Pushing Back Profitability

May 18, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...